Compare IT & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IT | RGC |
|---|---|---|
| Founded | 1979 | 2014 |
| Country | United States | Hong Kong |
| Employees | 40 | N/A |
| Industry | Other Consumer Services | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5B | 11.5B |
| IPO Year | 2010 | 2020 |
| Metric | IT | RGC |
|---|---|---|
| Price | $150.39 | $28.83 |
| Analyst Decision | Hold | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $189.25 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 158.0K |
| Earning Date | 05-05-2026 | 10-31-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 9.65 | N/A |
| Revenue | ★ $2,021,441,000.00 | N/A |
| Revenue This Year | $3.52 | N/A |
| Revenue Next Year | $5.08 | N/A |
| P/E Ratio | $15.54 | ★ N/A |
| Revenue Growth | ★ 13.30 | N/A |
| 52 Week Low | $139.18 | $9.39 |
| 52 Week High | $451.73 | $950.00 |
| Indicator | IT | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 45.23 | 51.89 |
| Support Level | $142.18 | $21.81 |
| Resistance Level | $162.87 | $29.26 |
| Average True Range (ATR) | 5.85 | 2.11 |
| MACD | 0.19 | -0.16 |
| Stochastic Oscillator | 43.83 | 35.05 |
Gartner Inc delivers actionable, objective business and technology insights that drive smarter decisions and stronger performance on an organization's mission-critical priorities. It delivers its products and services globally through three reportable segments - Business and Technology Insights, Conferences and Consulting. Insights equips executives and their teams from every Majority function, geography, industry and sector with actionable, objective insights, guidance and tools. Conferences provides executives and teams across an organization the opportunity to learn, share and network. and Consulting serves senior executives technology-driven strategic initiatives leveraging the power of Gartner's actionable, objective insight. The Majority revenue is derived from the Insights segment.
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.